About NousQ
NousQ is a company based in Singapore (Singapore) founded in 2021 by Gan Chee Wee and Lynne Lim.. NousQ has raised $1.6 million across 1 funding round. NousQ offers products and services including CLiKX. NousQ operates in a competitive market with competitors including AventaMed, Preceptis Medical, Tympanogen, Doya Medical and EntraTympanic, among others.
- Headquarter Singapore, Singapore
- Founders Gan Chee Wee, Lynne Lim
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nousq Pte. Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.6 M (USD)
in 1 rounds
-
Latest Funding Round
$1.6 M (USD), Seed
Jul 05, 2023
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NousQ
NousQ offers a comprehensive portfolio of products and services, including CLiKX. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Robotic device for automated and precise ear tube insertion.
Funding Insights of NousQ
NousQ has successfully raised a total of $1.6M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.6 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.6M
-
First Round
First Round
(05 Jul 2023)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Seed - NousQ | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by NousQ
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NousQ
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nousq Comparisons
Competitors of NousQ
NousQ operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AventaMed, Preceptis Medical, Tympanogen, Doya Medical and EntraTympanic, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Device for safe placement of grommets
|
|
| domain | founded_year | HQ Location |
Surgical tools for pediatric ear tube procedures are developed.
|
|
| domain | founded_year | HQ Location |
Provider of gel patch for chronic tympanic membrane perforations
|
|
| domain | founded_year | HQ Location |
Develops non-invasive stent technology for treating otitis media with effusion.
|
|
| domain | founded_year | HQ Location |
Medical device for the treatment of middle ear infections
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nousq
Frequently Asked Questions about NousQ
When was NousQ founded?
NousQ was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is NousQ located?
NousQ is headquartered in Singapore, Singapore.
Who is the current CEO of NousQ?
Lynne Lim is the current CEO of NousQ. They have also founded this company.
Is NousQ a funded company?
NousQ is a funded company, having raised a total of $1.6M across 1 funding round to date. The company's 1st funding round was a Seed of $1.6M, raised on Jul 05, 2023.
What does NousQ do?
NousQ was founded in 2021 in Singapore as a medical device company focused on surgical robotics. A robotic applicator for ear tube insertion is being developed to enable precise eardrum incisions. Commercially available ear tubes are utilized, with enhancements from sensor technology for safety. Operations aim to support outpatient procedures, reducing reliance on general anesthesia and microscopes. The sector involves pediatric otolaryngology innovations.
Who are the top competitors of NousQ?
NousQ's top competitors include Preceptis Medical, AventaMed and Tympanogen.
What products or services does NousQ offer?
NousQ offers CLiKX.